about
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron diseaseNeuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosisChronic over-nutrition and dysregulation of GSK3 in diseasesGlial Tau Pathology in Tauopathies: Functional ConsequencesMechanisms of neurodegeneration in amyotrophic lateral sclerosisDoxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytesAdvances in the treatment of anxiety: targeting glutamate.Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH.Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation.Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degenerationRapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes.Antibiotics that protect the brain.Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.Persistent at-level thermal hyperalgesia and tactile allodynia accompany chronic neuronal and astrocyte activation in superficial dorsal horn following mouse cervical contusion spinal cord injuryNeuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survivalDecreased EAAT2 protein expression in the essential tremor cerebellar cortex.Role of astrocytes in manganese mediated neurotoxicity.Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphologyIncreased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I.Effects of protons and HZE particles on glutamate transport in astrocytes, neurons and mixed cultures.Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies.Selective defect of in vivo glycolysis in early Huntington's disease striatumEffects of clonidine on the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationPotential drugs and methods for preventing or delaying the progression of Huntington's disease.Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder.Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicityAstrocyte dysfunction in neurological disorders: a molecular perspective.Is Huntington's a glutamine storage disease?Glutamate Limitation, BvgAS Activation, and (p)ppGpp Regulate the Expression of the Bordetella pertussis Type 3 Secretion SystemRole of oxidative stress in refractory epilepsy: evidence in patients and experimental models.Expression of Glutamate and GABA during the Process of Rat Retinal Synaptic Plasticity Induced by Acute High Intraocular Pressure.Multiple pathways contribute to the pathogenesis of Huntington disease.Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsyNMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neuronsBiotic acts of antibioticsEnhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model.
P2860
Q21262978-B376C170-8869-441A-B92C-8C1623A6642BQ24623266-A8E6B59A-1277-4478-ADD8-9B06C42242B0Q26738964-B03BD096-F652-47E8-944B-70E724DC494FQ26765365-4332C629-2443-4818-8882-9F9F5C882153Q28365454-F00B5AC3-0208-4E3D-94A8-E39B5D240911Q30278879-1C152209-03E1-4160-B69C-9E6EDD79E36FQ30457479-17F208E5-82FE-492F-AE3F-AA6754E0DFCFQ30492587-29E8453A-D022-4052-8466-25A1B379B4B2Q31063118-57E82823-FB98-40AA-8EC3-BBE8614B1814Q33284832-1D85B82C-6A48-4655-9D37-FDF12E1DDE10Q33429548-B6BCDF8A-F65A-4FE7-8DDD-E57A5E436D01Q33563621-BEC2A69A-7223-4B30-886D-C518D2DD0DD4Q33828702-07106EEA-0E50-40A9-A91D-9700A43854D4Q33833157-91911856-D1E7-4D67-8495-F817CEEB1543Q34053585-8F83B65D-1E64-456E-8AA8-74A6151AA342Q34277397-82C0C398-ED7C-4178-BC82-032E19632FC6Q34509446-38DD657B-0B95-4E0F-BC5E-69B74A94C80EQ34551549-A7C0D599-6805-4CE5-A28A-5AD0CC80B3DCQ34675523-1A4AD9DB-C408-42B5-9871-CCEB3E504EF7Q35099241-5ACBEE09-94E3-4B75-98FE-C153A5B51249Q35110544-40782F44-97C3-4DAF-8377-66F423AFDF72Q35115911-F1E48D14-1F78-4D68-8C90-9D1A64BF0348Q35170318-67972639-CEC5-4089-A7BB-1F5A59951B62Q35243263-CC7135F5-A4E0-4995-B401-E8D181C8DD35Q35634060-3DE64F54-7FBE-49CD-B891-62F1BBF7A50BQ35861415-10528692-EDF4-4D3F-86DD-F5C6F6B08275Q36117618-F6864F66-2C97-49C3-98F7-10EC51FDE608Q36142706-57FC0FAC-1518-4271-BCB9-D7BEDA99D827Q36212862-6C592039-E193-4FBB-81F1-F696140131F8Q36320596-098066C9-04D1-4BCB-B59D-CB334133F89EQ36404127-87348ACE-B52B-4240-8628-F2ECBD2B3C88Q36535666-1E760241-509F-4DBB-BFCC-8AA3FAE1F074Q36575042-DC97CD76-DE55-49EB-99C5-5820A21BD5A3Q36590070-7FCD0A78-7615-48E2-836C-CF027DAD2B44Q36681608-69BD091F-D223-41D9-860F-821A52CCDB2CQ36686156-96776418-B5CA-44A2-9DF8-97C091835BC5Q36740346-17D3B842-E6EE-443E-97E3-693F853AB4D5Q37050584-506B73E3-F2A4-4FFC-A915-63EF8B4EFEF8Q37101851-CD4BA11E-C780-4A5F-A2C4-028B193EAA1CQ37107185-909A1AFC-EE97-47FC-B081-0546A41348C3
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glutamate transporters in neurologic disease.
@ast
Glutamate transporters in neurologic disease.
@en
Glutamate transporters in neurologic disease.
@nl
type
label
Glutamate transporters in neurologic disease.
@ast
Glutamate transporters in neurologic disease.
@en
Glutamate transporters in neurologic disease.
@nl
prefLabel
Glutamate transporters in neurologic disease.
@ast
Glutamate transporters in neurologic disease.
@en
Glutamate transporters in neurologic disease.
@nl
P1433
P1476
Glutamate transporters in neurologic disease.
@en
P2093
Maragakis NJ
Rothstein JD
P304
P356
10.1001/ARCHNEUR.58.3.365
P577
2001-03-01T00:00:00Z